# Final Table Verification Report
## Comprehensive Cross-Check of Tables(tex)/ vs Source Papers

**Date:** 2026-01-22
**Method:** One agent per study (13 agents total)
**Source Papers:** all_papers_md/
**Tables Verified:** Tables(tex)/

---

## Executive Summary

| Study | Verified | Conflicts | Corrections Needed |
|-------|----------|-----------|-------------------|
| **Spahr 2025** | 15 | 2 | FPR value correction |
| **Reintjes 2025** | 15 | 2 | FPR range, AUC-ROC correction |
| **Fine 2025** | 20 | 0 | None |
| **Dong 2026** | 10 | 1 | Add PPV to Table 3 |
| **Wang 2025** | 12 | 2 | Remove incorrect specificity, add precision |
| **Singh 2024** | 11 | 3 | Personalization, specificity=precision correction |
| **Elemam 2025** | 18 | 5 | Paradigm, specificity precision, fusion, sensitivity range |
| **Borujeny 2013** | 10 | 4 | Trade-off config, Table 3 sensitivity |
| **Vieluf 2025** | 13 | 2 | Paradigm consistency, add precision |
| **Meisel 2020** | 12 | 2 | Algorithm description, clarify TiW vs FPR |
| **Stirling 2021** | 15 | 1 | Minor: RCH vs HRV terminology |
| **Nasseri 2021** | 14 | 2 | **MAJOR: AUC 0.75 vs 0.80** |
| **Ode 2023** | 10 | 2 | Add AUC-ROC to Table 3 |
| **TOTAL** | **165** | **27** | **Multiple corrections required** |

---

## Critical Corrections (High Priority)

### 1. Nasseri 2021 - AUC Value Conflict

| Location | Current Value | Correct Value | Evidence |
|----------|---------------|---------------|----------|
| Table 1B | AUC 0.80 (SD 0.15) | AUC 0.75 (SD 0.15) | Results section line 224-225 |
| Table 2B | AUC 0.75 | AUC 0.75 (SD 0.15) | Add SD for consistency |

**Explanation:** The abstract reports 0.80 (5 successful patients only), but Results section reports 0.75 (all 6 patients). The Results section value (0.75) is the correct cohort mean.

**Correction Required:**
```latex
% Table 1B:
\textbf{Nasseri 2021} & ... & AUC 0.75 (SD 0.15) & -- & TiW 0.9--7.2h/d \\
```

---

### 2. Spahr 2025 - FPR Value

| Location | Current Value | Correct Value | Evidence |
|----------|---------------|---------------|----------|
| Table 1A | <0.0125/h | 1/8 days (0.005/h) | Line 519: "FAR of 1/8 days" |
| Table 2A | 86--100% @ 0.01--0.5/day | 86--100% @ 1/8 days | Line 519 |

**Correction Required:**
```latex
% Table 1A:
\textbf{Spahr et al. 2025} & ... & 96\% & -- & 1/8 days (0.005/h) \\
```

---

### 3. Singh 2024 - Specificity vs Precision Confusion

| Location | Current Value | Correct Value | Evidence |
|----------|---------------|---------------|----------|
| Table 1A | Spec: 94.8% | Spec: -- (not reported) | 94.8% is precision, not specificity |

**Correction Required:**
```latex
% Table 1A:
\textbf{Singh Rathore 2024} & ... & 96.8\% & 94.8\% prec & -- \\
```

---

### 4. Wang 2025 - Incorrect Specificity Citation

| Issue | Details |
|-------|---------|
| Current table may show | Specificity: 93.1% |
| Source | This value is from Heldberg et al. (cited study), not Wang's own results |
| Correction | Remove specificity value - Wang does NOT report specificity |

---

## Table 1A (Detection Matrix) - All Corrections

| Study | Field | Current | Correction |
|-------|-------|---------|------------|
| **Spahr 2025** | FPR | <0.0125/h | 1/8 days (0.005/h) |
| **Reintjes 2025** | FPR | 1.91--39.75/h | No change (already correct) |
| **Singh 2024** | Spec | 94.8% | Remove (this is precision) |
| **Elemam 2025** | Sens (HRV) | 93--90% | 93% (not a range) |
| **Wang 2025** | Spec | (if 93.1% shown) | Remove - not reported |

---

## Table 1B (Forecasting Matrix) - All Corrections

| Study | Field | Current | Correction |
|-------|-------|---------|------------|
| **Vieluf 2025** | Para. | Feat | Hyb (Hybrid) |
| **Nasseri 2021** | Sens | AUC 0.80 (SD 0.15) | AUC 0.75 (SD 0.15) |

---

## Table 2A (Detection Architecture) - All Corrections

| Study | Field | Current | Correction |
|-------|-------|---------|------------|
| **Spahr 2025** | Trade-off Config | 86--100% @ 0.01--0.5/day | 86--100% @ 1/8 days |
| **Reintjes 2025** | Trade-off Config | 38.0--98.2% @ 1.91--40.5/h | 38.0--98.2% @ 1.91--39.75/h |
| **Elemam 2025** | Trade-off Config | 95.1% @ 97.1% spec | 95.1% @ 97.06% spec |
| **Borujeny 2013** | Trade-off Config | 90--100% @ 0--15% | k=5: 100% @ 0 false alarms |

---

## Table 2B (Forecasting Architecture) - All Corrections

| Study | Field | Current | Correction |
|-------|-------|---------|------------|
| **Vieluf 2025** | Paradigm | Hybrid | No change (Table 1B needs correction) |
| **Nasseri 2021** | Trade-off Config | AUC 0.75 @ TiW 0.9--7.2h/d | AUC 0.75 (SD 0.15) @ TiW 0.9--7.2h/d |

---

## Table 3 (Metrics Summary) - All Corrections

### Current Table 3 Issues

| Metric | Current Count | Correct Count | Studies to Add/Remove |
|--------|---------------|---------------|----------------------|
| **Sensitivity** | 8/9, 2/4 | 8/9, 1/4 | Forecasting: Meisel has value but Stirling/Nasseri do NOT report sensitivity |
| **Specificity** | 1/9, 0/4 | 3/9, 0/4 | Add: Wang, Vieluf |
| **FPR** | 7/9, 2/4 | 8/9, 0/4 | Detection: Add Singh. Forecasting: Meisel/Stirling report TiW, not FPR |
| **AUC-ROC** | 1/9, 2/4 | 3/9, 3/4 | Detection: Add Dong, Ode. Forecasting: Add Ode |
| **Detect. Latency** | 3/9, 1/4 | 4/9, 1/4 | Detection: Add Borujeny (0.6 s) |
| **Precision/PPV** | 2/9, 1/4 | 4/9, 1/4 | Detection: Add Dong, Singh, Elemam |
| **IoC/TiW** | 0/9, 2/4 | 0/9, 3/4 | Forecasting: Add Stirling (37 min) |

### Corrected Table 3

```latex
\begin{tabular}{lccc}
\toprule
\textbf{Metric} & \textbf{Detection (n=9)} & \textbf{Forecasting (n=4)} & \textbf{Reported By} \\
\midrule
Sensitivity/Recall & 8/9 & 1/4 & Spahr, Reintjes, Fine, Dong, Wang, \\
& & & Singh, Elemam, Ode \\
Specificity & 3/9 & 0/4 & Elemam, Vieluf, Wang \\
FPR/FA rate & 8/9 & 0/4 & Spahr, Reintjes, Fine, Dong, Wang, \\
& & & Singh, Elemam, Borujeny, Nasseri, Ode \\
AUC-ROC & 3/9 & 3/4 & Dong, Reintjes, Ode, Nasseri, Stirling \\
Detection Latency & 4/9 & 1/4 & Spahr, Fine, Elemam, Borujeny, Nasseri \\
Patient Success Rate & 2/9 & 3/4 & Reintjes, Meisel, Stirling, Nasseri, Ode \\
Precision/PPV & 4/9 & 1/4 & Dong, Singh, Elemam, Ode \\
IoC / Time in Warning & 0/9 & 3/4 & Meisel, Stirling, Nasseri \\
\bottomrule
\end{tabular}
```

---

## Detailed Study-by-Study Findings

### Spahr et al. 2025

**Status:** 15 verified, 2 conflicts

| Field | Conflict | Resolution |
|-------|----------|------------|
| Sample | n=384, 49 CSs | Clarify: 49 CSs in test set (103 total) |
| FPR | <0.0125/h | Correct: 1/8 days = 0.005/h |

**Action:** Update FPR in both Table 1A and Table 2A

---

### Reintjes et al. 2025

**Status:** 15 verified, 2 conflicts

| Field | Conflict | Resolution |
|-------|----------|------------|
| FPR (Table 2A) | 40.5/h | Correct: 39.75/h |
| AUC-ROC (Table 3) | Listed YES | Should be NO - not reported |

**Action:** Update FPR range, remove from AUC-ROC list

---

### Fine 2025

**Status:** 20 verified, 0 conflicts

**Action:** None required

---

### Dong et al. 2026

**Status:** 10 verified, 1 conflict

| Field | Conflict | Resolution |
|-------|----------|------------|
| PPV (Table 3) | Not listed | Should be YES: PPV = 0.334 reported |

**Action:** Add Dong to Precision/PPV in Table 3

---

### Wang et al. 2025

**Status:** 12 verified, 2 conflicts

| Field | Conflict | Resolution |
|-------|----------|------------|
| Specificity | 93.1% cited | This is from Heldberg et al., not Wang |
| Precision (Table 3) | Not listed | Should be YES: 83.2%, 87.1%, 95.3%, 95.8% |

**Action:** Remove incorrect specificity, add to Precision/PPV list

---

### Singh Rathore et al. 2024

**Status:** 11 verified, 3 conflicts

| Field | Conflict | Resolution |
|-------|----------|------------|
| Personalization | Glb (single pt) | Should be: CS (Case Study) or -- |
| Specificity | 94.8% | This is precision, not specificity |
| Fusion | Early | Implied but not explicit |

**Action:** Update personalization, move 94.8% to precision

---

### Elemam et al. 2025

**Status:** 18 verified, 5 conflicts

| Field | Conflict | Resolution |
|-------|----------|------------|
| Paradigm (Table 1) | Hyb | Should be: CNN (separate from rule-based questionnaire) |
| Specificity | 97.1% in Table 2A | Correct: 97.06% |
| Sensitivity (HRV) | 93--90% | Should be: 93% (not a range) |
| Fusion | "No fusion" | Clarify: three independent modules |
| FPR | Listed as YES | The FPR values are from Song et al. (cited), not Elemam |

**Action:** Multiple corrections across tables

---

### Borujeny et al. 2013

**Status:** 10 verified, 4 conflicts

| Field | Conflict | Resolution |
|-------|----------|------------|
| Sensitivity (Table 3) | Listed as NO | Should be YES: 100% for KNN k=5 |
| Trade-off Config | 90--100% @ 0--15% | Not explicitly stated - use: k=5: 100% @ 0 false alarms |
| FPR | 0 | Technically correct for k=5, but clarify |
| Detection Latency | Should be YES | 0.6 s reported |

**Action:** Update Table 3 sensitivity listing, clarify trade-off

---

### Vieluf et al. 2025

**Status:** 13 verified, 2 conflicts

| Field | Conflict | Resolution |
|-------|----------|------------|
| Paradigm (Table 1B) | Feat | Should be: Hyb (handcrafted features + DNN) |
| Precision (Table 3) | Listed as NO | Should be YES: weighted precision = 0.89 |

**Action:** Update paradigm in Table 1B, add to Precision list

---

### Meisel et al. 2020

**Status:** 12 verified, 2 conflicts

| Field | Conflict | Resolution |
|-------|----------|------------|
| Algorithm | LSTM + 1D Conv | 1D Conv was comparison only, main: LSTM (10 units) |
| FPR column | Shows "TiW 43.7%" | TiW is NOT FPR - clarify this distinction |

**Action:** Clarify algorithm, ensure TiW vs FPR distinction in notes

---

### Stirling et al. 2021

**Status:** 15 verified, 1 minor conflict

| Field | Conflict | Resolution |
|-------|----------|------------|
| Algorithm description | HRV feat | More precise: RCH (rate of change in HR) |

**Action:** Minor clarification acceptable

---

### Nasseri et al. 2021

**Status:** 14 verified, 2 conflicts

| Field | Conflict | Resolution |
|-------|----------|------------|
| AUC | 0.80 vs 0.75 | **CRITICAL**: Correct is 0.75 (all 6 patients) |
| Paradigm | E2E vs Hybrid | Should be: Hybrid (FFT + SQI + time features) |

**Action:** **URGENT** - Update AUC to 0.75 in both tables

---

### Ode et al. 2023

**Status:** 10 verified, 2 conflicts

| Field | Conflict | Resolution |
|-------|----------|------------|
| AUC-ROC (Table 3) | Not listed | Should be YES: AUC = 0.97 |
| Sample notation | n=66, 85 szs | Clarify: 85 preictal episodes |

**Action:** Add Ode to AUC-ROC list in Table 3

---

## Summary Statistics After Corrections

### Paradigm Distribution
| Paradigm | Count | Percentage |
|----------|-------|------------|
| Feature-based | 5 | 38% |
| End-to-end | 3 | 23% |
| Hybrid | 3 | 23% |
| Ensemble | 1 | 8% |
| Anomaly | 1 | 8% |

### Modality Count
| Type | Count | Percentage |
|------|-------|------------|
| Single-modal | 5 | 38% |
| Multi-modal | 8 | 62% |

### Personalization
| Type | Count | Percentage |
|------|-------|------------|
| Global | 9 | 69% |
| Patient-specific | 2 | 15% |
| Mixed/Other | 2 | 15% |

---

## Recommended Action Plan

1. **URGENT:** Fix Nasseri 2021 AUC value (0.80 -> 0.75)
2. **HIGH:** Fix Spahr 2025 FPR value (<0.0125/h -> 1/8 days)
3. **HIGH:** Fix Singh 2024 specificity/precision confusion
4. **MEDIUM:** Update Table 3 with all corrections
5. **MEDIUM:** Fix paradigm inconsistencies (Vieluf, Nasseri)
6. **LOW:** Minor terminology clarifications

---

## Verification Methodology

Each study was verified by a dedicated agent that:
1. Read the full source paper from `all_papers_md/`
2. Compared each table claim against paper content
3. Reported line number evidence for each verification
4. Flagged conflicts with recommended corrections

Total papers verified: 13
Total claims checked: ~192
Critical conflicts found: 5
Minor conflicts found: 22

---

**Report Generated:** 2026-01-22
**Verification Status:** Complete
